งานวิจัยและนวัตกรรม

Efficacy and early complications of intravenous busulfan in children with thalassemia undergoing hematopoietic stem cell transplantation.

Pakakasama S, Chuansumrit A, Damkong B, Sirachainan N, Sirireung S, Hongeng S.

Hematology/Oncology and Stem Cell Therapy. 2008 Jul 1;1(3):189-92.

Allogeneic stem cell transplantation for children with acquired severe aplastic anaemia: a retrospective study by the Viva-Asia Blood and Marrow Transplantation Group.

Chen J, Lee V, Luo CJ, Chiang AK, Hongeng S, Tan PL, Tan AM, Sanpakit K, Li CF, Lee AC, Chua HC, Okamoto Y.

British journal of haematology. 2013 Aug;162(3):383-91.

Pretransplant Immunosuppression followed by reduced-toxicity conditioning and stem cell transplantation in high-risk thalassemia: a safe approach to disease control.

Anurathapan U, Pakakasama S, Rujkijyanont P, Sirachainan N, Songdej D, Chuansumrit A, Sirireung S, Charoenkwan P, Jetsrisuparb A, Issaragrisil S, Ungkanont A, Sruamsiri R, Srisala S, Andersson BS, Hongeng S.

Biology of Blood and Marrow Transplantation. 2013 Aug 1;19(8):1259-62.

Outcomes of Thalassemia Patients Undergoing Hematopoietic Stem Cell Transplantation by Using a Standard Myeloablative versus a Novel Reduced Toxicity Conditioning Regimen According to a New Risk Stratification.

Anurathapan U, Pakakasama S, Mekjaruskul P, Sirachainan N, Songdej D, Chuansumrit A, Charoenkwan P, Jetsrisuparb A, Sanpakit K, Pongtanakul B, Rujkijyanont P, Meekaewkunchorn A, Sruamsiri R, Ungkanont A, Issaragrisil S, Andersson BS, Hongeng S.

Biology of Blood and Marrow Transplantation. 2014 Dec 1;20(12):2066-71.

Curative Stem Cell Transplantation for Severe Hb H Disease Manifesting From Early Infancy: Phenotypic and Genotypic Analyses.

Surapolchai P, Sirachainan N, So CC, Hongeng S, Pakakasama S, Anurathapan U, Chuansumrit A.

Hemoglobin. 2016 Jan 2;40(1):70-3.

A Novel Approach of Hematopoietic Stem Cell Transplantation for Severe Thalassemia from Haploidentical Donors with Favorable Outcomes.

Anurathapan U, Hongeng S, Pakakasama S, Sirachainan N, Songdej D, Chuansumrit A, Andersson BS.

Biology of Blood and Marrow Transplantation. 2016 Mar 1;22(3):S365-6.

The Effect of Mycophenolate Mofetil on Graft Versus Host Disease in Cyclosporine Induced Thrombotic Microangiopathy after Allogeneic Hematopoietic Stem Cell Transplantation.

Niparuck P, Pukiat S, Puavilai T, Ativitavas T, Ungkanont A.

J Bone Res. 2016;4(165):2.

Survival Benefit of Intravenous Busulfan (120 mg/M2) and Fludarabine Myeloablative Regimen for Treatment of Myeloid Malignancies.

Niparuck P, Pukiat S, Puavilai T, Ativitavas T, Chantrathammachart P.

J Stem Cell Res Ther. 2016;6(338):2.

Hematopoietic stem cell transplantation for homozygous β-thalassemia and β-thalassemia/hemoglobin E patients from haploidentical donors.

Anurathapan U, Hongeng S, Pakakasama S, Sirachainan N, Songdej D, Chuansumrit A, Charoenkwan P, Jetsrisuparb A, Sanpakit K, Rujkijyanont P, Meekaewkunchorn A, Lektrakul Y, Lamsirirak P, Surapolchai P, Satayasai W, Sirireung S, Sruamsiri R, Wahidiyat PA, Ungkanont A, Issaragrisil S, Andersson BS.

Bone marrow transplantation. 2016 Jun;51(6):813-8.

Lentiglobin gene therapy for transfusion-dependent β-thalassemia: update from the Northstar Hgb-204 phase 1/2 clinical study.

Thompson AA, Kwiatkowski J, Rasko J, Hongeng S, Schiller GJ, Anurathapan U, Cavazzana M, Ho PJ, von Kalle C, Kletzel M, Leboulch P, Vichinsky E, Petrusich A, Asmal M, Walters MC.

Blood. 2016 Dec 2;128(22):1175.

Cyclophosphamide vs salvage chemotherapy plus G-CSF as chemo-mobilization in Asian patients undergoing autologous hematopoietic stem cell transplant.

Issaragrisil S, Cheng-Hwai T, Bunworasate U, Su-Peng Y, Hung LY, Tee GY, Wahid SF, Chin NS, Puavilai T, Gin GG, Piu KL, Wen-Li H, Tsai-Yun C, Numbenjapon T.

Bone marrow transplantation. 2017 Feb;52(2):299-300.

Bacteremia during neutropenic episodes in children undergoing hematopoietic stem cell transplantation with ciprofloxacin and penicillin prophylaxis.

Choeyprasert W, Hongeng S, Anurathapan U, Pakakasama S.

International journal of hematology. 2017 Feb;105:213-20.

Successful haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide in a child with X-linked chronic granulomatous disease: A first report in Asia.

Janjindamai C, Manuyakorn W, Anurathapan U, Pakakasama S, Wattanasirichaigoon D, Kamchaisatian W, Benjaponpitak S, Hongeng S.

Asian Pacific Journal of Allergy and Immunology. 2022 Sep 1;40(3):278-82.

Haplo-Identical Stem Cell Transplantation with Post-Transplant Cyclophosphamide in High-Risk Pediatric Hematologic Malignancies: A Comparison of TBI-Based Conditioning Regimen with Thiotepa-Based Conditioning Regimen.

Anurathapan U, Tannumsaeng S, Pongpitcha P, Lerthammakiat S, Songdej D, Pakakasama S, Sirachainan N, Hongeng S.

Biology of Blood and Marrow Transplantation. 2019 Mar 1;25(3):S191-2.

No differences in hemostatic and endothelial activations between haploidentical and matched-donor hematopoietic stem cell transplantation in thalassemia disease.

Lertthammakiat S, Sitthirat P, Anurathapan U, Songdej D, Pakakasama S, Chuansumrit A, Putawornsub N, Sirasittikarn S, Wantanawijarn S, Kadegasem P, Hongeng S, Sirachainan N.

Thrombosis Journal. 2020 Dec;18:1-5.

Immune responses to hepatitis B vaccination after hematopoietic stem cell transplantation in pediatric and young adult patients.

Chaichotjinda K, Anurathapan U, Boonsathorn S, Chaisavaneeyakorn S, Treepongkaruna S, Techasaensiri C, Apiwattanakul N.

Clinical Transplantation. 2020 Oct;34(10):e14024.

CMV-reactive NK cells in pediatric post-hematopoietic stem cell transplant.

Apiwattanakul N, Hongeng S, Anurathapan U, Pakakasama S, Srisala S, Klinmalai C, Andersson BS.

InTransplantation proceedings 2020 Jan 1 (Vol. 52, No. 1, pp. 353-359). Elsevier.

Hematopoietic stem cell transplantation from an infected SARS-CoV2 donor sibling.

Anurathapan U, Apiwattanakul N, Pakakasama S, Pongphitcha P, Thitithanyanont A, Pasomsub E, Hongeng S.

Bone Marrow Transplantation. 2020 Dec;55(12):2359-60.

Hematopoietic stem cell transplantation for severe thalassemia patients from haploidentical donors using a novel conditioning regimen.

Anurathapan U, Hongeng S, Pakakasama S, Songdej D, Sirachainan N, Pongphitcha P, Chuansumrit A, Charoenkwan P, Jetsrisuparb A, Sanpakit K, Rujkijyanont P, Meekaewkunchorn A, Lektrakul Y, Lamsirirak P, Surapolchai P, Sirireung S, Sruamsiri R, Wahidiyat PA, Andersson BS.

Biology of Blood and Marrow Transplantation. 2020 Jun 1;26(6):1106-12.

A clinical and histological comparison between acute cutaneous graft‐versus‐host disease and other maculopapular eruptions following hematopoietic stem cell transplantation: a retrospective cohort.

Chanprapaph K, Leerunyakul K, Niparuck P, Rutnin S.

International Journal of Dermatology. 2021 Jan;60(1):60-9.

Chronic graft-versus-host disease in children and adolescents with thalassemia after hematopoietic stem cell transplantation.

Lertkovit O, Anurathapan U, Hongeng S, Thokanit NS, Pakakasama S.

International Journal of Hematology. 2021 Apr;113:556-65.

Immunogenicity of vero cell culture-derived Japanese encephalitis vaccine in pediatric and young hematopoietic stem cell transplantation recipients.

Assawawiroonhakarn S, Apiwattanakul N, Pakakasama S, Hongeng S, Anurathapan U, Yoksan S, Klinmalai C, Sae-Chew P, Techasaensiri C.

The Pediatric Infectious Disease Journal. 2021 Mar 1;40(3):264-8.

Bloodstream bacterial infections in thalassemic pediatric and adolescent patients after hematopoietic stem cell transplantation.

Chaya W, Anurathapan U, Rattanasiri S, Techasaensiri C, Pakakasama S, Apiwattanakul N.

Pediatric Transplantation. 2022 Mar;26(2):e14168.

Association between adenovirus infection and mortality outcome among pediatric patients after hematopoietic stem cell transplant.

Wiriyachai T, Chaya W, Anurathapan U, Rattanasiri S, Boonsathorn S, Chaisavaneeyakorn S, Techasaensiri C, Apiwattanakul N.

Transplant Infectious Disease. 2021 Dec;23(6):e13742.